Join us on 7 March to discuss the impact of revision of the EU’s General Pharmaceutical Legislation (GPL) on Europe’s innovation ecosystem and biotechnology companies.
The Biomanufacturing Policy Summit will host its 2nd edition in March 2024. The invite-only half-day summit hosted by EuropaBio brings together stakeholders including industry representatives and […]
A Science | Business closed-door roundtable, organised in partnership with EuropaBio – followed by networking reception Only By Invitation For more information, please contact: denitsa.nikolova@sciencebusiness.ne
Against the backdrop of the Belgian EU Council Presidency, the Rare Diseases Forum 2024 brings together senior leaders from across patient organisations, industry and policy to […]
"Policy pathways for biomanufacturing in Europe" was the theme of the Biomanufacturing Policy Summit 2024. The upcoming report will summarise the Summit's keynote speeches and panel […]
We are thrilled to announce that AseBio will hold the fifth edition of the AseBio Investor Day at the gorgeous Kursaal conference center in San Sebastián […]
Get ready for the touchdown of Europe's finest life sciences conference, Knowledge for Growth, on May 16, 2024, in the vibrant city of Antwerp, Belgium!Elevate your […]
Explore how industrial biotechnologies can achieve Europe’s environmental ambitions. Discussions will centre on exploring both regulatory frameworks and technological advancements, identifying our core strengths and opportunities, […]
EuropaBio, bio.be/essenscia, and flanders.bio biotechnology associations are organising a summer reception in Brussels for its members and invited guests to mark the end of the Belgium Council Presidency […]
Over the millennia science & technology have steadily advanced, but key unsolved challenges remain, and much more is possible. The Curious – Future Insight™ Conference brings […]
To celebrate the start of European Biotech Week, EuropaBio is organising a webinar to discuss the critical intersection of legislation and investment into innovation within the biotech industry.
To celebrate the start of European Biotech Week, EuropaBio is organising a webinar to discuss the critical intersection of legislation and investment into innovation within the biotech industry.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
